Media

Media contact

Media library

Fast facts

Page last modified 13 March 2019

Compliance Hotline Report Adverse Drug Reaction

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.

Choose region and then country

Other Lundbeck sites

Global contacts

Media

Welcome to the media section

Latest releases

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Double-digit growth for all strategic brands in 9M 2019 and FY 2019 guidance raised

Lundbeck completes the acquisition of Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention

Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SEC

Lundbeck and Takeda announce Ministry of Health, Labour and Welfare (MHLW) approval of Trintellix ® in Japan

Media contact

General press enquiries, please call +45 3643 4000

Media library

Access visual aids for stories about Lundbeck

Fast facts

Get a quick overview of Lundbeck and our business